Bal Pharma Ltd.
| BSE: 524824 | Sector: Health care |
| NSE: BALPHARMA | ISIN Code: INE083D01012 |
| BSE 00:00 | 27 May | 99.25 |
-1.25 (-1.24%) |
OPEN
102.15 |
HIGH
102.15 |
LOW
98.50 |
| NSE 00:00 | 27 May | 99.45 |
-1.15 (-1.14%) |
OPEN
101.55 |
HIGH
104.00 |
LOW
97.50 |
| OPEN | 102.15 |
| PREVIOUS CLOSE | 100.50 |
| VOLUME | 2777 |
| 52-Week high | 148.50 |
| 52-Week low | 88.00 |
| P/E | 15.18 |
| Mkt Cap.(Rs cr) | 155 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Bal Pharma Ltd. (BALPHARMA) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Aurobindo Pharma | 529.60 | -5.90 | -1.10 | 15823.68 |
| Cipla | 966.30 | 1.90 | 0.20 | 13900.58 |
| Dr Reddy's Labs | 4392.00 | 84.75 | 1.97 | 13349.10 |
| Sun Pharma.Inds. | 903.95 | 3.40 | 0.38 | 12803.21 |
| Lupin | 606.15 | 5.40 | 0.90 | 11055.93 |
| Apollo Hospitals | 3861.60 | 193.60 | 5.28 | 9153.00 |
| Zydus Lifesci. | 373.65 | 0.80 | 0.21 | 7790.40 |
| Glenmark Pharma. | 398.05 | 4.45 | 1.13 | 7567.93 |
| Alkem Lab | 3042.05 | 17.70 | 0.59 | 7219.68 |
| Divi's Lab. | 3514.45 | 65.30 | 1.89 | 6798.61 |
| Torrent Pharma. | 2939.85 | 38.95 | 1.34 | 6450.83 |
| Ipca Labs. | 901.85 | -15.30 | -1.67 | 5114.11 |
| Alembic Pharma | 733.45 | -5.20 | -0.70 | 5051.44 |
| Laurus Labs | 566.60 | 7.40 | 1.32 | 4768.72 |
| Abbott India | 17950.15 | 251.30 | 1.42 | 4310.02 |
| Gland Pharma | 2906.70 | 53.45 | 1.87 | 3462.88 |
| Glaxosmi. Pharma | 1519.30 | 6.05 | 0.40 | 3193.74 |
| Granules India | 266.60 | 8.00 | 3.09 | 3134.98 |
| Sanofi India | 6518.45 | -16.35 | -0.25 | 2956.60 |
| Ajanta Pharma | 1723.60 | -4.70 | -0.27 | 2718.59 |
Quick Links for Bal Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
